SomaLogic Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SomaLogic Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3448
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies and aptamers, which is used in clinical diagnosis of EDTA plasma, citrate plasma, serum, CSF, tissue homogenate, cell lysates and conditioned cell media. SomaLogic’s SOMAscan assay is a protein biomarker discovery and development tool for protein measurement solutions. It offers protein-measurement assays, kits, and reagents for life science and biopharma researchers. The company serves biological and medical science sectors. SomaLogic is headquartered in Boulder, Colorado, the US.

SomaLogic Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SomaLogic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SomaLogic Inc, Medical Devices Deals, 2012 to YTD 2018 9
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SomaLogic Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
SomaLogic Raises Funds through Venture Financing 11
SomaLogic Raises USD44.9 in Venture Financing 12
SomaLogic Raises USD163 Million in Venture Financing 13
SomaLogic Raises US$10 Million In Venture Financing 14
Private Equity 15
SomaLogic Raises USD200 Million in Financing Round 15
Partnerships 16
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 16
SomaLogic Inc – Key Competitors 17
SomaLogic Inc – Key Employees 18
SomaLogic Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Apr 02, 2018: Melody Harris, J.D., Appointed Chief Legal Officer of SomaLogic 20
Apr 05, 2017: SomaLogic announces the appointment of long-time Board member as Chief Executive Officer 21
Government and Public Interest 22
Nov 16, 2017: An immune system timeline for tuberculosis progression 22
Oct 16, 2017: Modified DNA aptamer inhibits IL-1 alpha signaling 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
SomaLogic Inc, Pharmaceuticals & Healthcare, Key Facts 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SomaLogic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SomaLogic Inc, Deals By Therapy Area, 2012 to YTD 2018 8
SomaLogic Inc, Medical Devices Deals, 2012 to YTD 2018 9
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SomaLogic Raises Funds through Venture Financing 11
SomaLogic Raises USD44.9 in Venture Financing 12
SomaLogic Raises USD163 Million in Venture Financing 13
SomaLogic Raises US$10 Million In Venture Financing 14
SomaLogic Raises USD200 Million in Financing Round 15
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 16
SomaLogic Inc, Key Competitors 17
SomaLogic Inc, Key Employees 18

List of Figures
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SomaLogic Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SomaLogic Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OUE Ltd:戦略・SWOT・企業財務分析
    OUE Ltd - Strategy, SWOT and Corporate Finance Report Summary OUE Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Genome Institute of Singapore:製薬・医療:M&Aディール及び事業提携情報
    Summary Genome Institute of Singapore (GIS) is a research institute that provides research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It operates technology and comprises early career researchers such …
  • Findel plc:企業の戦略・SWOT・財務情報
    Findel plc - Strategy, SWOT and Corporate Finance Report Summary Findel plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bellway Plc (BWY):企業の財務・戦略的SWOT分析
    Bellway Plc (BWY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Vedanta Resources Plc:企業のM&A・事業提携・投資動向
    Vedanta Resources Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vedanta Resources Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Mohawk Industries, Inc.:企業の戦略・SWOT・財務分析
    Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • New York Power Authority:企業の戦略・SWOT・財務情報
    New York Power Authority - Strategy, SWOT and Corporate Finance Report Summary New York Power Authority - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • University of Pittsburgh-製薬・医療分野:企業M&A・提携分析
    Summary University of Pittsburgh (Pitt) is an educational research institute that offers undergraduate, graduate and professional programs. The institute provides academic courses in different fields such as business, information sciences, health and rehabilitation, information sciences, engineering …
  • H3 Biomedicine Inc-製薬・医療分野:企業M&A・提携分析
    Summary H3 Biomedicine Inc (H3 Biomedicine), a subsidiary of Eisai Co Ltd is a biopharmaceutical company that offers therapies. The company concentrates on discovery and early development of novel, targeted anti-cancer compounds. Its products include small-molecule drugs that are developed by utiliz …
  • Arris International Plc
    Arris International Plc - Strategy, SWOT and Corporate Finance Report Summary Arris International Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Odonate Therapeutics Inc (ODT):製薬・医療:M&Aディール及び事業提携情報
    Summary Odonate Therapeutics Inc (Odonate), formerly Odonate Therapeutics LLC, is a pharmaceutical company that develops medicines for the treatment of cancer. The company provides product candidate, tesetaxel which is a novel orally administered taxane used for the treatment of advanced and metasta …
  • Vitasoy International Holdings Ltd (0345):企業の財務・戦略的SWOT分析
    Vitasoy International Holdings Ltd (0345) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • MEC Holding GmbH:企業の戦略的SWOT分析
    MEC Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • ScanSource Inc (SCSC):企業の財務・戦略的SWOT分析
    ScanSource Inc (SCSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Texas Instruments Incorporated (TXN):医療機器:M&Aディール及び事業提携情報
    Summary Texas Instruments Incorporated (TI) designs and manufactures and sells semiconductors to electronics designers and manufacturers the world over. It offers catalog and application-specific standard semiconductor products through its analog chips and embedded processors divisions. Its analog c …
  • Brodrene Hartmann A/S:企業の戦略・SWOT・財務情報
    Brodrene Hartmann A/S - Strategy, SWOT and Corporate Finance Report Summary Brodrene Hartmann A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Caris Life Sciences Inc:企業の製品パイプライン分析
    Summary Caris Life Sciences Inc (Caris Life) is a biotechnology company. The company’s molecular scientific offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make personalized treatment decisions. Its ADAPT biotargeting system, is a plat …
  • Nuvo Pharmaceuticals Inc (NRI):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver dr …
  • Vergnet SA (ALVER):企業の財務・戦略的SWOT分析
    Vergnet SA (ALVER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • TheraDiag SA (ALTER):医療機器:M&Aディール及び事業提携情報
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆